Quotient Sciences Acquires Arcinova

Read the press release here

Arcinova Invests in Uniqsis FlowSyn™ Continuous Flow Reactor

The addition of the Uniqsis FlowSyn™ reactor will enable Arcinova to develop and simplify the scale-up of a challenging API batch process. 

 

Read the full article

 




Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.

GET IN TOUCH